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Abstract A gene named stpZ+, coding for a 17.5kDa protein, 
that rescues cdc25-22 when overexpressed, has been previously 
Lolated from fission yeast. Here we describe the expression and 
purification of Stpl protein as a fusion with the glutathione 9 
transferase in E. coli and its kinetic characterisation. Stpl de- 
duced protein sequence shows an high homology to members of 
a class of cytosolic low IV, protein phosphatase previously known 
to exist only in mammalian species. Stpl has a kinetic behaviour 
that appears to be intermediate with respect to the two isoenzy- 
matic forms of low M, protein tyrosine phosphatases present in 
mammalian tissues. These differing kinetic characteristics are 
mainly due to the sequence 45-56 that is spatially close to the 
active site pocket. 
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I. Introduction 
Protein tyrosine phosphorylation plays a crucial role in reg- 
: Jating many aspects of cell division, proliferation and differen- 
I iation [l-3]. The cellular phosphotyrosine level is regulated by 
I he relative activities of phosphotyrosine protein kinases 
I PTKs) and phosphotyrosine protein phosphatases (PTPases). 
I’TKs activity is enhanced by external stimuli (i.e. growth fac- 
I ors and hormones) and this leads to increased phosphorylation 
I-vels in proteins involved in signal transduction. The impor- 
I ante of tyrosine-phosphorylation regulation system is well 
riemonstrated in yeast cell cycle control. The phosphorylation 
1 If cdc2 (a component of the maturation promoting factor) on 
1 yrosine, carried out by two protein tyrosine kinases, wee1 and 
rnikl, is an inhibitory signal to mitosis [4,5]. On the other hand, 
tiephosphorylation of cdc2 predominantly performed by the 
I dc25 protein phosphatase leads to restore mitosis [&lo]. 
A gene named stpl+ coding for a 17.5-kDa protein was iso- 
.ated by screening a cDNA expression library for clones that 
vere able to rescue cdc25-22 [ll]. Stpl deduced protein se- 
luence shows a high similarity to a family of mammalian low 
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M, protein tyrosine phosphatase (LMW-PTP). The LMW-PTP 
is a cytosolic enzyme expressed in all eukaryotic organisms 
showing specific PTPase activity on tyrosine phosphorylated 
proteins and peptide substrates [12-151 and have the active site 
motif CysX,Arg, present in all known types of protein tyrosine 
phosphatases. Site directed mutagenesis and kinetic studies 
have proven that the Cys” residue in CX,R is directly involved 
in the catalytic mechanism of the enzyme: the Cys12Ser mutant 
shows, in fact, a total loss of activity [16]. 
Two isoforms of the enzyme have been isolated [17,18] in 
various mammalian tissues. They originated from a single gene 
through an alternative splicing mechanism and they differ in 
40-73 zone. The two isoforms of the LMW-PTP called PTPfast 
and PTPslow in human and ACPl and ACP2 in rat liver, were 
isolated in our and other laboratories [17-191. On the basis of 
sequence similarity, kinetic properties and cyclic guanosine 
monophosphate- (cGMP) dependent activation, these enzymes 
were classified in two distinct groups: IF1 (isoform-1) which 
includes PTPfast and ACPl, and IF2 (isoform-2) including 
PTPslow, ACP2 and bovine liver PTPase. The biological func- 
tions of mammalian LMW-PTPs are still unknown but the 
discovery of a yeast homologue suggests that they must play an 
important role because of their high sequence conservation 
through evolution. 
The purpose of this study was to investigate the relationship 
between structure and function of LMW-PTPs previously iso- 
lated in our laboratories and the recombinant Stpl. For this 
reason we cloned the stpl’ gene in a suitable E. coli expression 
vector to produce Stpl protein. The recombinant product was 
analysed in order to compare this enzyme to IF1 and IF2. We 
also describe the mutagenesis of Stpl protein on Cys” residue 
to Ser on the basis of LMW-PTP mutagenesis previously re- 
ported [16]. The results confirm the involvement of Cys” in the 
active site of Stpl molecule. 
2. Materials and methods 
T4 DNA ligase, restriction enzymes, polynucleotide kinase were from 
Promega. Taq DNA polymerase, deossinucleotides were from Perkin 
Elmer. Isopropylthiogalactoside (IPTG) was from Inalco. Sequenase 
was from USB. [a-“P]ATP (3000 Cilmmol) were from NEN. pGEX-2T 
vector was from Pharmacia. DH.5a E. coli strain (BRL) was used for 
plasmid propagation and mutagenesis, TBl bacterial strain (New Eng- 
land Biolabs) was used for expression of the recombinant fusion pro- 
teins. Glutathione, bovine thrombin, glutathione-agarose affinity gel, 
pNPP and cGMP were from Sigma. All other reagents were analytical 
grade or the best commercially available. Chemically synthesised ol- 
igonucleotides were obtained from Pharmacia. 
2.1. Construction of pGEX-STPl and pGEX-STPl CIlS plasmids 
Two synthetic primers were synthesised: a direct one (S-GGCCG- 
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CGGATCCACCAAGAATATTCAAGTA) whose 3’ ends was identi- 
cal to the sequence coding for the first six amino acid residues in Stpl 
coding sequence cloned in Bluescript plasmid, and a reverse one 
(5’-GGCCGCGAATTCAAACTTAAACTAAGCA) whose 3’ ends 
was complementary to the 3’ non -coding region of the stpZ’ gene (kind 
gift of Dr. Paul Russell, La Jolla, CA). These primers, harbouring the 
restriction site for BnmHI and EcoRI, respectively, were used in a PCR 
experiment to obtain the codifying sequence for the expression of Stpl 
as fusion protein. The template for this amplification was the 
Bluescript plasmid harbouring the stpl’ gene. In order to create 
the Cys” mutant to Ser, a direct primer where the TGC codon for Cys” 
was substituted with the TCT codon for Ser, was synthesised and used 
in the PCR experiment. The resulting fragments from PCR, coding for 
the entire sequence of Stpl protein and for the StplCllS mutated 
protein were purified on agarose gel and digested with BurnHI and 
EcoRI restriction enzymes. These fragments were separately ligated 
into the pGEX-2T vector previously digested with the same enzymes 
to create the corresponding sticky ends. The fragments were conse- 
quently inserted downstream and in frame with the glutathione S- 
transferase coding sequence. The recombinant plasmids named pGEX- 
STPl pGEX-STPlCllS were separately used to transform the DH5 
E. coli strain. 
2.2. Screening of recombinant clones 
Transformants were analysed in order to isolate clones harbouring 
the recombinant plasmids (pGEX-STPl and pGEX-STPlCllS, respec- 
tively) and expressing either the recombinant Stpl fusion protein or the 
StplCl IS mutant. Twenty clones, from the recombinant Stpl and from 
the StplCllS mutated protein, were assayed for the expression of 
fusion protein. Colonies were inoculated in 1 ml of LB and grown for 
1 h at 37°C. After the induction of expression adding 0.2 mM IPTG, 
cells were harvested by centrifugation, resuspended in 200 ~1 of 20 mM 
3,3_dimethylglutarate buffer pH 7.0, and sonicated for a few seconds. 
The clear lysates were assayed on 12% SDS-PAGE according to 
Laemmli [20]. The clones showing an evident sharp band of the molec- 
ular weight corresponding to the fusion proteins, were isolated. Dou- 
ble-stranded DNA sequencing was performed in order to control that 
PCR amplification did not introduce any undesired mutation in Stpl 
sequence and in the mutated StplCl 1s one. These clones were used for 
massive expression of the two recombinant proteins. 
In order to verify that the activity of stpl’ gene product was 
similar to the related mammalian proteins, we have expressed 
the Stpl protein in E. coli as fusion protein with GST: this 
system allows rapid purification and was demonstrated to be 
very efficient with mammalian LMW-PTP. To do that, a PCR 
amplification was performed on Bluescript harbouring the 
stpl’ gene previously isolated by Mondesert et al. [l 11, intro- 
ducing a BamHI and a EcoRI restriction sites at the two ends 
of the amplified sequences: the corresponding sites on the 
pGEX-2T vector were used for cloning this fragment. 
In parallel to that we have also created a Cys”-to-Ser mutant, 
corresponding to the Cys”-to-Ser mutant of LMW-PTP, that 
we have demonstrated to have lost any catalytic activity [12]. 
For this purpose an oligonucleotide direct mutagenesis was 
performed, followed by the direct cloning of the mutated ampli- 
fied sequence in the pGEX-2T vector. In this way the Stpl and 
StplCl 1s sequences were placed downstream and in frame 
2.3. Expression and puriJcation of recombinant and mutated proteins 
TBl E. coli strains was transformed with pGEX-STPl and pGEX- 
kDa 
STPlCllS separately. 5 ml overnight culture were added to 500 ml of 
LB containing 100 mg/l of ampicillin. Culture were grown at 37°C 
under shaking and after two hours were supplemented with 0.2 mM 
IPTG to induce the expression of the recombinant proteins. The culture 
were grown for 6 h at 37°C under shaking. After centrifugation at 
8000 x g for 30 min at 4°C the pellets were resuspended in l/100 (v/v) 
of 20 mM 3,3_dimethylglutarate buffer pH 7.0, 200 mM NaCl, 10 mM 
2-mercaptoethanol and 1 mM EDTA. Cells were disrupted by sonica- 
tion at 20 kHz and 100 W and after centrifugation, as previously 
described by Modesti et al. [21], the two clear lysates containing the 
recombinant and mutated proteins respectively were separately applied 
to a glutathione-agarose affinity column equilibrated with a 20 mM 
3,3_dimethylglutarate buffer pH 7.0, containing 200 mM NaCl, 10 mM 
2-mercaptoethanol and 1 mM EDTA. The proteins were purified with 
an affinity chromatography procedure as described by Taddei et al. [22] 
and the recombinant proteins were separately eluted with 5 mM re- 
duced glutathione. Protein concentration was measured by bicinchon- 
inic acid assay. 
06.0 
45.5 
2.4. Thrombin cleavage 
The fusion proteins were incubated for 1 hat room temperature with 
1:500 (w/w) bovine thrombin in 50 mM Tris-HCl buffer pH 8.0, con- 
taining 150 mM NaCl and 2.5 mM CaCl, The Stpl protein was 
separated from GST and uncleaved fusion protein by a second affinity 
chromatography on the same column equilibrated with the 50 mM 
Tris-HCl buffer pH 8.0. 
10.4 
14.2 
2.5. Enzyme ussay and kinetic parameters Fig. 1. SDS-PAGE analysis of recombinant proteins. Lanes 1 and 
The main kinetic parameters of the recombinant Stpl protein and of 2 = Stpl and StplCllS cleaved proteins; lanes 3 and 4 = Stpl and 
the StplCl 1s mutant enzyme were determined by measuring the initial StplCl 1s recombinant fusion proteins; lane 5 = molecular weight 
hydrolysis rate on p-nitrophenylphosphate (pNPP) and L-phospho- standard. 
tyrosine (L-P-Tyr) as follows: the substrates were dissolved in 1 ml of 
0.1 M acetate buffer pH 5.5, 1 mM EDTA and incubated in water bath 
at 37°C. The reaction started by adding a suitable samples volume and 
stopped by 1 ml of 1 M NaOH. The phenols produced by enzymatic 
activity was measured spectrophotometrically using E,,, = 18,000 
M-’ ‘cm-’ for p-nitrophenol and &2975 = 2,330 Mm’.cm-’ for 
tyrosine in alkali solution. K,,, and V,,, were determined in duplicate 
by plotting the initial substrate hydrolysis rate versus its initial concen- 
tration, using a non-linear fitting. The activation of the enzyme at 
saturating cGMP concentration was determined according to Cirri et 
al. [23]. Free phosphate generated by hydrolysis of Tyr-phosphorylated 
peptides was evaluated with malachite green assay [24]. 
3. Results and discussion 
3.1. Cloning, mutagenesis and expression of stpl+ and 
stp 1 ‘C 11 S genes 
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40 50 60 70 
IF1 ACPl RIDSAATSTYEVGNPPDYRGQNCMKKHGIHMQHI 
Bfast _V______G--I---_-----S___R___P_S_V 
STPl ----CG-GAWH---R--P-TLEVL--N---TK-L 
IF2 ACP2 A---S-V-DWN--R---P-AV--LRN---STA-K 
Bslow V---G-V-DWN--RS--P-AVS-LRN----TA-K 
BOV-PTP V---G-V-DWN--RS--P-AVS-LRN---NTA-K 
1 ‘ig. 2. Sequence alignment of the 40-73 zone of LMW-PTP and Stpl 
KPl and ACP2 are from rat liver, Bslow and Bfast are from human 
I rythrocytes, bov-PTP is from bovine liver, Stpl is from fission yeast. 
I lashes indicate identity with ACPI. Numbers are refer to amino acids 
osition in the proteins. 
with the sequence coding for GST. DH5 E. coli cells were 
ransformed with the two recombinant plasmids and assayed 
or protein expression: the supernatants of E. coli cells express- 
ng the two recombinant fused proteins were separated on a 
2% SDS-PAGE together with a control from cells transformed 
vith the pGEX-2T vector alone. Sharp bands corresponding to 
he expected fusion protein molecular weight are evident for the 
%lones harbouring the two recombinant plasmids (data not 
hown). Clones with the correct insertion were completely 
hecked by DNA sequencing with the Sanger method to con- 
rol any undesired mutation in the sequences due to PCR am- 
llification. The two recombinant plasmids pGEX-STPI and 
JGEX-STPlCl lS, were used to transform the TBl strain in 
rrder to enhance, after induction with IPTG, the expression of 
he two proteins. 
The two recombinant fusion proteins were cleaved with 
hrombin as reported in section 2. The cleavage time was re- 
luced as much as possible in order to achieve a high cleavage 
ield avoiding significant enzyme denaturation. The two re- 
‘.ombinant proteins were separated from GST by a second 
tffinity chromatography. Fractions containing the pure pro- 
eins were pooled, concentrated by ultrafiltration and checked 
or purity by SDS-PAGE as shown in lanes 1 and 2 of Fig. 1 
n comparison with the recombinant fusion proteins (lanes 3 
tnd 4). With this method it is possible to obtain up to 20 mg/l 
)f purified fusion protein. This value is very similar to that 
obtained for LMW-PTP, confirming this method to be ex- 
remely efficient for the production of this class of proteins. 
ferences between IF1 and IF2 isoforms can be shown using 
these substrates. Moreover, IF2 activity can be enhanced by 
cGMP addition. In this work our purpose was to: (i) verify that 
Stpl has a PTPase activity similar to LMW-PTP; and (ii) which 
of the two LMW-PTP isoforms shows a more similar behaviour 
respect to Stpl. Concerning the first point. the main kinetic 
constants (k,., and K,,,) of the recombinant Stpl protein, were 
determined with two different substrates: pNPP and L-P-Tyr. 
The K, and k,,, on pNPP show lower values for Stpl with 
respect to those from IF1 and IF2 isoenzymes; on L-P-Tyr the 
K,, for Stp I is equal to the same value from IF1 meanwhile the 
kcut value is lower with respect to both IF1 and IF2 (Table 1). 
This values are in any case comparable to those of both 
isoforms indicating that Stpl has an enzymatic activity very 
similar to that of LMW-PTP. Stpl is also totally inactive of 
other phosphorylated amino acids, such as P-Ser and P-Thr: 
this fact should exclude a dual specificity of this enzyme, in 
analogy with LMW-PTP. In addition, Stpl activity was tested 
on a Tyr-phosphorylated peptide. For this purpose a synthetic 
peptide covering the sequence 7677776 of the PDGF-R mole- 
cule was treated with the enzyme and free phosphate was eval- 
uated. In analogy to LMW-PTP characteristics. Stpl is active 
also on this substrate (data not shown). 
Analysis of the activity of the StplCl IS mutant that we have 
created, confirms that the activity of this PTPase is very similar 
to that of LMW-PTP: no enzymatic activity was detectable, 
indicating that this mutation, in analogy with the C12S mutated 
LMW-PTP. completely abolishes the functionality of the en- 
zyme. It is very likely that also in the case of Stpl, the Cys 
contained in the CXXXXXR motif is essential in the catalytic 
mechanism of the enzyme. Further experiments will clarify 
whether also in this case the inability to form thiophosphate 
intermediate is causing this effect, in order to demonstrate the 
identity of the mechanism of action with respect to LMW-PTP. 
For what the similarity of Stpl with the two different LMW- 
PTP is concerned, we have to notice that the amino acid resi- 
dues within the 40-73 divergent sequence of mammalian se- 
quences are involved in the differing kinetic behaviour of the 
two isoenzymes. These structural differences, in fact, might 
distinguish important in vivo roles for these isoenzymes (Cirri 
et al. [25]; manuscript submitted). Comparison the portion of 
Stpl sequence 40-73 corresponding to the 40-72 divergent se- 
quence of IF1 and IF2 (Fig. 2) shows a comparable percentage 
of identity with both isoforms (51% and 45%. respectively), 
highlighting Stpl as a third type of PTPase intermediate be- 
tween mammalian IF1 and IF2 isoforms. 
F.2. Kinetic parametrrs of‘ the recombinant Stpl and mututed 
Stpl Cl IS protrim 
LMW-PTP activity was assayed on pNPP and L-P-Tyr. Dif- 
In order to clarify the relationship between Stpl with IF1 and 
IF2 isoforms. we have consider the k,,,lK,,, ratio. The k,,,lK, 
is an apparent second-order rate constant that refers to the 
properties and the reactions of the free enzyme and free sub- 
rable 1 
iatalytic parameters values with p-NPP and L-P-Tyr of IFl, IF2 and Stpl (refer to the text for details) 




k,,lK, k Ldi K,, k,,,lK,, cGMP 
(s-1) (se’mM_‘) (s-l) (mM) (ss’mM_‘) 
FI 15.0 * 0.5 0.070 5 0.01 214 14.6 f 0.6 0.6 k 0.04 24.3 1.3 
F2 29.2 f 1.1 0.19 f 0.03 154 11.9 k 0.5 5.8 t 0.10 2.0 9.0 
;TPl 5.3 f 0.2 0.028 f 0.01 189 5.0 + 0.1 0.6 k 0.05 8.4 5.0 
:GMP maximum activation values are also indicated. Values are means of at least three independent determinations. S.E.M. are indicated. 
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strate. Results in Table 1 show that Stpl kc,,/&, ratios on both 
substrates have a value that is intermediate in comparison with 
those of the two isoforms. With the same purpose we also 
measured the cGMP-dependent activation of Stpl. This nucle- 
otide increases IF2 catalytic activity but has a poor effect on 
IF1 [23]. Stpl display again an intermediate position between 
the two isoforms, showing a cGMP activation ratio higher with 
respect to IF1 but lower with respect to IF2 (Table 1). 
Recently, by means of site directed mutagenesis, we have 
demonstrated that the differing kinetic behaviour of IF1 and 
IF2 was mainly due to amino acids in position 49 and 50 (Cirri 
et al. [25], manuscript submitted). In particular the Asn’” resi- 
due of IF2 is both responsible of cGMP activation ratio and 
differing kinetic constant values between IF1 and IF2. Data 
obtained for Stpl confirm this findings: residue 50 of Stpl is 
an His while in IF1 and IF2 there are Glu and Asn, respectively. 
Accordingly Stpl kinetic characteristic are different from both 
IF1 and IF2 ones. Furthermore the Trp49 of IF2 (Fig. 2) is 
partially involved only in cGMP activation. In position 49 Stpl 
has a Trp residue and consequently is able to partially maintain 
the capability of being activated by cGMP (Table 1). Hence, 
Stpl appears to be an intermediate isoform between eukaryotic 
IF1 and IF2. Probably this in vitro kinetic differences may 
reflect in vivo different regulation pathway and substrate spec- 
ificity of this class of enzyme. 
In conclusion, Stpl can be considered as a new member of 
the LMW-PTP family, on the basis of its enzymatic activity and 
of the key role that the Cys of the characteristic CXXXXXR 
motif shows. The fact that Stpl demonstrate to have intermedi- 
ate characteristics with respect to mammalian IF1 and IF2 do 
not exclude that other members of this family could be ex- 
pressed in fission yeast, as suggested also by the fact that killing 
of the stpl’ gene do not cause any apparent phenotype in yeast 
[ll]: further investigation are necessary to try to clarify this 
point. 
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